石四药集团(02005)10月21日斥资608.13万港元回购210万股

Core Viewpoint - The company, Stone Four Pharmaceutical Group, announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company will repurchase 2.1 million shares at a total cost of HKD 6.0813 million [1] - The buyback price per share is set between HKD 2.88 and HKD 2.92 [1] - The buyback is scheduled to take place on October 21, 2025 [1]